phenotypeId,phenotypeName,referentConceptId,clinicalDescription,literatureReview,phenotypeNotes
4253901000,Juvenile idiopathic rheumatoid arthritis,4253901,"Overview: Is a heterogenous group of chronic idiopathic inflammatory disorder primarily involving joints, with the peak incidence of JRA occurred at one to three years of age, with a preponderance of girls in this age group. Nomenclature of this disease has been referred to by various older terms such as juvenile rheumatoid arthritis (JRA, in the United States) and juvenile chronic arthritis (JCA, in Europe). Systemic juvenile idiopathic arthritis (sJIA, formerly called Still's disease or systemic juvenile rheumatoid arthritis) is a subtype of JIA that includes daily fever in a quotidian pattern, rash, and arthritis.Presentation: The clinical manifestations is chronic arthritis among children, with onset before 16 years of age, lasting at least 6 weeks and unknown etiology. Assessment: It is a diagnosis of exclusion. The disease is classified into oligoarthritis, polyarthritis, rheumatoid factor positivity, Plan: Treatment is symptom management and with DMARDs. If refractory, biologics (IL-6 inhibitors, TNF-alpha inhibitors) are considered among those previously treated with NSAIDs + glucocorticosteroids +/- methotrexate. Prognosis: Early referral to pediatric rheumatologist is recommended to prevent progression to crippling joint disease with function reduction.",NA,NA
